Myomo (NYSEAMERICAN:MYO) Director Buys $24,750.00 in Stock

Myomo, Inc. (NYSEAMERICAN:MYO) Director Thomas Kirk bought 25,000 shares of Myomo stock in a transaction dated Thursday, May 28th. The stock was purchased at an average price of $0.99 per share, with a total value of $24,750.00. Following the purchase, the director owned 653,863 shares in the company, valued at approximately $647,324.37. This represents a 3.98% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Myomo Stock Performance

NYSEAMERICAN MYO opened at $1.10 on Thursday. Myomo, Inc. has a 1 year low of $0.61 and a 1 year high of $3.08. The company has a debt-to-equity ratio of 1.21, a current ratio of 2.73 and a quick ratio of 2.36. The firm has a market cap of $42.50 million, a price-to-earnings ratio of -3.06 and a beta of 1.47. The company has a fifty day moving average price of $0.84 and a 200-day moving average price of $0.86.

Analysts Set New Price Targets

Separately, Craig Hallum reiterated a “buy” rating on shares of Myomo in a research report on Tuesday, March 10th. Four analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $7.67.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in MYO. Bank of America Corp DE raised its position in shares of Myomo by 93.6% in the third quarter. Bank of America Corp DE now owns 30,412 shares of the company’s stock worth $27,000 after buying an additional 14,705 shares in the last quarter. Wells Fargo & Company MN grew its position in Myomo by 103.1% during the fourth quarter. Wells Fargo & Company MN now owns 38,707 shares of the company’s stock worth $35,000 after buying an additional 19,646 shares in the last quarter. Invesco Ltd. bought a new position in Myomo in the 2nd quarter worth about $37,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in Myomo in the 2nd quarter worth about $38,000. Finally, Jane Street Group LLC purchased a new stake in shares of Myomo in the 4th quarter valued at about $64,000. Institutional investors own 44.99% of the company’s stock.

About Myomo

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.